[Clinical Characteristics of Patients with Ph Mixed Phenotype Acute Leukemia].
Jia, Yan-Nan; Li, Yan; Gong, Xiao-Yuan; Liu, Kai-Qi; Ye, Lei; Wang, Hui-Jun; Li, Qing-Hua; Li, Cheng-Wen; Wang, Ying; Wang, Jian-Xiang; Mi, Ying-Chang.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 27(2): 354-359, 2019 Apr.
Artigo em Chinês | MEDLINE | ID: mdl-30998137
[Long Non Coding RNA RP11-69I8.3 Expression in Acute Leukemia and Its Cinical Significance].
[Clinical Characteristics and Prognosis of patients with Variant Philadelphia Chromosome Positive Leukemia].
Clinical characteristics and outcomes of mixed phenotype acute leukemia with Philadelphia chromosome positive and/or bcr-abl positive in adult.
How I treat mixed-phenotype acute leukemia.
Philadelphia chromosome-like acute lymphoblastic leukemia.
Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Is Separated into Two Subgroups Associated with Survival by BCR-ABL Fluorescence in situ Hybridization of Segmented Cell Nuclei: Report from a Single Institution.
[Clinical Analysis of 208 Patiets with BCR/ABL Negative Myeloproliferative Neoplasms].
[Clinical efficacy of switching to 2nd generation of tyrosine kinase inhibitor on CML patients at poor responses to imatinib].
Successful treatment of Philadelphia chromosome-positive mixed phenotype acute leukemia by appropriate alternation of second-generation tyrosine kinase inhibitors according to BCR-ABL1 mutation status.
BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features.